Patents by Inventor Fengfeng Mao

Fengfeng Mao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE ACE2 AND FUSION PROTEIN, AND APPLICATIONS THEREOF
    Publication number: 20230348880
    Abstract: A soluble ACF and a truncated form thereof, a fusion protein thereof and preparation methods therefor. A soluble ACEI and a truncated form thereof, as well as a use of the fusion protein in the preparation of a drug for an ACEI-related disease.
    Type: Application
    Filed: February 27, 2021
    Publication date: November 2, 2023
    Applicant: National Institute of Biological Sciences, Beijing
    Inventors: Wenhui Li, Yonghe Qi, Jianhe Chen, Jianhua Sui, Juan Liu, Fengfeng Mao, Ximing Liu
  • NTCP inhibitors
    Patent number: 10961231
    Abstract: The invention provides cyclosporin A analogues that are NTCP inhibitors and useful for treating HBV and/or HDV infection(s), hepatoprotection and amelioration of hypercholesterolemia, diabetes and inhibiting cancer.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: March 30, 2021
    Assignee: National Institute of Biological Sciences, Beijing
    Inventors: Zhiyuan Zhang, Wenhui Li, Hanying Ruan, Yang Liu, Fengfeng Mao, Ying Li, Zhongmin Zhou
  • NTCP Inhibitors
    Publication number: 20210040072
    Abstract: The invention provides cyclosporin A analogues that are NTCP inhibitors and useful for treating HBV and/or HDV infection(s), hepatoprotection and amelioration of hypercholesterolemia, diabetes and inhibiting cancer.
    Type: Application
    Filed: October 12, 2020
    Publication date: February 11, 2021
    Applicant: National Institute of Biological Sciences, Beijing
    Inventors: Zhiyuan Zhang, Wenhui Li, Hanying Ruan, Yang Liu, Fengfeng Mao, Ying Li, Zhongmin Zhou